Cover Image

Computational Design of Novel Tau-Tubulin Kinase 1 Inhibitors for Neurodegenerative Diseases

The tau-tubulin kinase 1 (TTBK1) protein is a casein kinase 1 superfamily member located at chromosome 6p21.1. It is expressed explicitly in the brain, particularly in the cytoplasm of cortical and hippocampal neurons. TTBK1 has been implicated in the phosphorylation and aggregation of tau in Alzhei...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shahzaib Ahamad (Author), Iqbal Taliy Junaid (Author), Dinesh Gupta (Author)
Format:	Book
Published:	MDPI AG, 2024-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tau Protein Biosensors in the Diagnosis of Neurodegenerative Diseases
by: Jafar Sadeghzadeh, et al.
Published: (2023)

Computational drug discovery of potential TAU protein kinase I inhibitors using in silico docking studies
by: Arumugam Madeswaran, et al.
Published: (2013)

Design, synthesis and biological evaluation of novel diarylpyridine derivatives as tubulin polymerisation inhibitors
by: Shanbo Yang, et al.
Published: (2022)

Design, synthesis and molecular docking of novel diarylcyclohexenone and diarylindazole derivatives as tubulin polymerization inhibitors
by: Riham I. Ahmed, et al.
Published: (2017)

Design and evaluation of albumin nanoparticles for the delivery of a novel β-tubulin polymerization inhibitor
by: Alessandra Spada, et al.
Published: (2021)

Synthesis, Computational Analysis, and Antiproliferative Activity of Novel Benzimidazole Acrylonitriles as Tubulin Polymerization Inhibitors: Part 2
by: Anja Beč, et al.
Published: (2021)

Design, synthesis and evaluation of dihydro-1H-indene derivatives as novel tubulin polymerisation inhibitors with anti-angiogenic and antitumor potency
by: Shengtao Xu, et al.
Published: (2023)

Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors
by: Guangcheng Wang, et al.
Published: (2021)

An Innovative Approach to Address Neurodegenerative Diseases through Kinase-Targeted Therapies: Potential for Designing Covalent Inhibitors
by: Swapnil P. Bhujbal, et al.
Published: (2023)

Tubulin/microtubules as novel clozapine targets
by: Mizuki Hino, et al.
Published: (2022)

Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-β formation
by: Huang-Ju Tu, et al.
Published: (2024)

Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities
by: Romeo Romagnoli, et al.
Published: (2022)

Discovery of dual tubulin-NEDDylation inhibitors with antiproliferative activity
by: Dong-Jun Fu, et al.
Published: (2023)

Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results
by: Jin-Bon Hong, et al.
Published: (2022)

Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of Sphingosine Kinase 1
by: Sonam Roy, et al.
Published: (2020)

Design, synthesis and biological evaluation of novel podophyllotoxin derivatives as tubulin-targeting anticancer agents
by: Yujin Guo, et al.
Published: (2024)

Antiproliferative benzothiazoles incorporating a trimethoxyphenyl scaffold as novel colchicine site tubulin polymerisation inhibitors
by: Dong-Jun Fu, et al.
Published: (2020)

Novel pyrimidine Schiff bases and their selenium-containing nanoparticles as dual inhibitors of CDK1 and tubulin polymerase: design, synthesis, anti-proliferative evaluation, and molecular modelling
by: Samar El-Kalyoubi, et al.
Published: (2023)

A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors
by: Wenjing Liu, et al.
Published: (2022)

New Multi-Targeted Antiproliferative Agents: Design and Synthesis of IC261-Based Oxindoles as Potential Tubulin, CK1 and EGFR Inhibitors
by: Momen R. Fareed, et al.
Published: (2021)

Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer
by: Faez Iqbal Khan, et al.
Published: (2020)

Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity
by: Mourad AAE, et al.
Published: (2020)

The Src-Kinase Fyn is Required for Cocaine-Associated Memory Through Regulation of Tau
by: Hongchun Li, et al.
Published: (2022)

Synthesis and antitumor activity of litseaone B analogues as tubulin polymerisation inhibitors
by: Wei Yang, et al.
Published: (2022)

Cytotoxic substituted indolizines as new colchicine site tubulin polymerisation inhibitors
by: Monica-Cornelia Sardaru, et al.
Published: (2020)

Phenothiazine- and Carbazole-Cyanochalcones as Dual Inhibitors of Tubulin Polymerization and Human Farnesyltransferase
by: Andreea Zubaș, et al.
Published: (2023)

Discovery of novel arylamide derivatives containing piperazine moiety as inhibitors of tubulin polymerisation with potent liver cancer inhibitory activity
by: Xiao-Yi Shi, et al.
Published: (2023)

1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders
by: Ondrej Benek, et al.
Published: (2018)

A QSAR Study on the 4-Substituted Coumarins as Potent Tubulin Polymerization Inhibitors
by: Leila Dinparast, et al.
Published: (2020)

Recurrence of the oxazole motif in tubulin colchicine site inhibitors with anti-tumor activity
by: Marilia Barreca, et al.
Published: (2021)

Design, Synthesis, Molecular Docking, and Biological Evaluation of Pyrazole Hybrid Chalcone Conjugates as Potential Anticancer Agents and Tubulin Polymerization Inhibitors
by: Md. Jahangir Alam, et al.
Published: (2022)

Inhibition of Polo-like Kinase 1 Prevents the Male Pronuclear Formation Via Alpha-tubulin Recruiting in In Vivo-fertilized Murine Embryos
by: Jeonghyeon Moon, et al.
Published: (2018)

Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations
by: Antonio Curcio, et al.
Published: (2024)

S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer
by: Zhenyan Hou, et al.
Published: (2023)

Design and synthesis of doublecortin-like kinase 1 inhibitors and their bioactivity evaluation
by: Pengming Pan, et al.
Published: (2024)

Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities
by: Hamada Hashem, et al.
Published: (2024)

Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer
by: Sachin Sharma, et al.
Published: (2023)

Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs
by: Gisele Barbosa, et al.
Published: (2022)

PERUBAHAN BENTUK DAN MAKNA PATUNG TAU-TAU TORAJA
by: Simatupang, Devi Oktavia
Published: (2017)

Tau oligomers
by: Jesus Avila
Published: (2014)